ODAC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
ODAC
Apr 30, 2024, 07:31 |
Insight
Top 5 posts of the week by Cancer Network
Cancer Network shared on their X/Twitter page: "View our top 5 posts of the week:…
Apr 25, 2024, 21:33 |
Blog
C. Ola Landgren: It was an honor to present the EVIDENCE meta-analysis at ODAC
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Apr 14, 2024, 12:56 |
Insight
Carl Ola Landgren: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs
Carl Ola Landgren, Professor of Medicine, Chief of Myeloma Division at University of Miami, shared…
Mar 20, 2024, 16:53 |
Insight
Vincent Rajkumar: ODAC votes 11-0 to recommend approval of Cilta-Cel in patients with relapsed/refractory multiple myeloma in earlier stages
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X/Twitter: "Breaking: ODAC votes…
Mar 17, 2024, 13:43 |
Insight
Samer Al Hadidi: How to counsel patients about Cilta Cel
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, made the following post on X/Twitter:…
Oct 28, 2023, 15:53 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 10
Our 2023 OncoDaily series on '100 Influential Women in Oncology: Key Opinion Leaders to Follow…
Oct 9, 2023, 18:53 |
Career
Daniel E. Spratt: It is a huge honor to be the 1st radonc as a full standing member on the FDAs ODAC (I am at least told).
Daniel E. Spratt, Chair of the Department of Radiation Oncology at University Hospitals Cleveland Medical…
All:
7
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube